Lymphocyte migration patterns in organ allograft recipients.
A central tenet of immunology is the observation, made 30 years ago, that lymphocytes recirculate continuously between peripheral blood and lymphoid tissues. In recent years, the subject of lymphocyte migration, both under physiological conditions and in states of alloresponsiveness, has become more enigmatic. It lies outside most current topics of immunological investigations, labelling and tracing techniques are problematic, and many experimental findings are phenomenological and difficult to interpret. Indeed, our overall knowledge of the functional differences between the various host lymphoid compartments and their constituent cell populations remains rudimentary. However, as understanding increases regarding the host immunological events responding to an antigenic stimulus such as a graft, with growing definition of the distinctive and interconnecting roles of lymphocyte subpopulations and their products acting on each other to produce graft destruction, the conceptual importance of lymphocyte migration again is becoming obvious. This role includes many facets of immunity such as the effects of antigen specificity, immunologic memory, differential behavior of recirculating or sessile populations, and local and systemic contact between antigen and effector cells. It has become evident that lymphocytes migrate in a non-random and highly dynamic fashion determined by a range of specific and non-specific factors; in the setting of organ transplantation, patterns are profoundly affected by the interrelated cellular and humoral components of the immunological cascade which may lead either to graft rejection or to its prolongation in untreated and immunologically modified recipients, respectively. Thus, the traffic of lymphocytes throughout host lymphoid and non-lymphoid compartments and their activity within these compartments should be considered an integral part of the host immunomodulation triggered by transplantation of histoincompatible tissue. Gradual filling of the gaps in our current knowledge on the mechanistic aspects of this phenomenon will not only contribute to basic science itself, but also should lead to the development of innovative therapeutic approaches to treat graft rejection.
Kupiec-Weglinski
J W
JW
Surgical Research Laboratory, Harvard Medical School, Boston MA.
Tilney
N L
NL
D000818:Animals; D016026:Bone Marrow Transplantation; D002465:Cell Movement; D003524:Cyclosporins / Q000494:pharmacology; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000145:classification / Q000276:immunology / Q000502:physiology*; D008221:Lymphoid Tissue / Q000502:physiology; D009928:Organ Specificity; D011828:Radiation Chimera; D051381:Rats; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D003524:Cyclosporins